Twist Bioscience officer proposes $136K share sale
Prior-sale entries run from August 3 to October 2, 2026; the latest listed transaction involved 10,088 common shares.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Twist Bioscience Corp officer Paula Green reported a proposed sale of 1,007 common shares through Fidelity Brokerage Services LLC, with an aggregate market value of $136,349.51 and an approximate sale date of November 3, 2026. The shares are listed as coming from restricted stock vesting on November 2, 2026; the remarks say the sale includes an amount to cover a resulting tax obligation. Daniel Tucci signed as a duly authorized representative of Fidelity Brokerage Services LLC and attorney-in-fact for Paula Green.
Key Figures
Key Terms
Rule 144 regulatory
aggregate market value financial
vested equity award distribution financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.